These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29437229)

  • 1. IL-27: a double agent in the IL-6 family.
    Jones GW; Hill DG; Cardus A; Jones SA
    Clin Exp Immunol; 2018 Jul; 193(1):37-46. PubMed ID: 29437229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy.
    Xie Q; Huang C; Li J
    Autoimmunity; 2015 Mar; 48(2):69-72. PubMed ID: 25483133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.
    Xu WD; Zhang M; Zhang YJ; Ye DQ
    Hum Immunol; 2013 Sep; 74(9):1057-60. PubMed ID: 23800433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
    Jones SA; Jenkins BJ
    Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 and its activators in intestinal defense and mucosal homeostasis.
    Hruz P; Dann SM; Eckmann L
    Curr Opin Gastroenterol; 2010 Mar; 26(2):109-15. PubMed ID: 20040863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.
    Rath T; Billmeier U; Waldner MJ; Atreya R; Neurath MF
    Arch Toxicol; 2015 Apr; 89(4):541-54. PubMed ID: 25632846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.
    Sonnenberg GF; Fouser LA; Artis D
    Nat Immunol; 2011 May; 12(5):383-90. PubMed ID: 21502992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
    Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
    Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis.
    Kragstrup TW; Andersen T; Heftdal LD; Hvid M; Gerwien J; Sivakumar P; Taylor PC; Senolt L; Deleuran B
    Front Immunol; 2018; 9():2226. PubMed ID: 30319661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
    Leng RX; Pan HF; Tao JH; Ye DQ
    Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting interleukin-21 in rheumatoid arthritis.
    Yuan FL; Hu W; Lu WG; Li X; Li JP; Xu RS; Li CW; Chen FH; Jin C
    Mol Biol Rep; 2011 Mar; 38(3):1717-21. PubMed ID: 20848219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
    Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
    Lott JM; Sumpter TL; Turnquist HR
    J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies.
    Naseem S; Hussain T; Manzoor S
    Cytokine Growth Factor Rev; 2018 Feb; 39():36-45. PubMed ID: 29361380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cIAP1/2-TRAF2-SHP-1-Src-MyD88 Complex Regulates Lipopolysaccharide-Induced IL-27 Production through NF-κB Activation in Human Macrophages.
    Busca A; Konarski Y; Gajanayaka N; O'Hara S; Angel J; Kozlowski M; Kumar A
    J Immunol; 2018 Mar; 200(5):1593-1606. PubMed ID: 29358273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro.
    Boutet MA; Najm A; Bart G; Brion R; Touchais S; Trichet V; Layrolle P; Gabay C; Palmer G; Blanchard F; Le Goff B
    Ann Rheum Dis; 2017 Jul; 76(7):1304-1312. PubMed ID: 28288964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.
    Cayrol C; Girard JP
    Curr Opin Immunol; 2014 Dec; 31():31-7. PubMed ID: 25278425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation.
    Ouyang W; O'Garra A
    Immunity; 2019 Apr; 50(4):871-891. PubMed ID: 30995504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 mice.
    Talabot-Ayer D; Martin P; Vesin C; Seemayer CA; Vigne S; Gabay C; Palmer G
    J Immunol; 2015 Jan; 194(2):750-60. PubMed ID: 25505285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.